Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Merck
Cerilliant
Chinese Patent Office
Farmers Insurance
Novartis
Colorcon
Teva
Federal Trade Commission
AstraZeneca

Generated: October 21, 2017

DrugPatentWatch Database Preview

Drug Master Files for: argatroban

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
7801AII12/8/1988MITSUBISHI TANABE PHARMA CORPMCI-9038 ARGATROBAN DRUG SUB.
20709AII7/20/2007CHEMWERTH INCARGATROBAN HYDRATE (NON-STERILE BULK) DRUG SUBSTANCE
20760AII8/7/2007EUTICALS SPAARGATROBAN
21304AII1/30/2008LUNDBECK PHARMACEUTICALS ITALY SPAARGATROBAN
22855AII8/14/2009CHEMWERTH INCINTERMEDIATE 6 OF ARGATROBAN (ARGA 6)
22935III7/10/2009SCINOPHARM TAIWAN LTDARGATROBAN
25400AII10/27/2011GLAND PHARMA LTDARGATROBAN MONOHYDRATE
25765AII3/19/2012EMCURE PHARMACEUTICALS LTDARGATROBAN MONOHYDRATE
25893III2/20/2012ALP PHARM BEIJING CO LTDARGATROBAN HYDRATE
28030AII5/15/2014GLAND PHARMA LTDARGATROBAN MONOHYDRATE (PROCESS-II)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
Mallinckrodt
Cerilliant
Moodys
Colorcon
Cantor Fitzgerald
Fish and Richardson
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot